Question 1

How many institutions own SLXN stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SLXN shares is 9, representing 4.23% of the company's common stock.

Question 2

Who are the major shareholders selling Silexion Therapeutics Ltd. stock?

Accepted Answer

UBS GROUP AG, in the last quarter, reduced its stake in SLXN by -69.43% restricting it's holding to 517 shares of worth nearly $662.00. SBI SECURITIES CO., LTD. also lessened -98.11% of the SLXN shares from its portfolio, reducing its holding to 20 shares of worth $26.00. N/A also shunned SLXN shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying SLXN stock?

Accepted Answer

As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in SLXN by 71.45% in the last quarter. The institutional holder raised its holding to 20.93 thousand shares having worth more than $26.79K. TWO SIGMA SECURITIES, LLC also added 100% more shares of SLXN to its portfolio, raising its holding to 11.66 thousand shares of worth $14.92K. N/A also increased its SLXN shares holding by N/A which brought its holding to - shares worth -.

Question 4

SLXN's major insiders: who are they?

Accepted Answer

The insider with the most stakes in SLXN is Shirvan Mitchell , CSO and CDO at the company. Additionally, SLXN stock is highly held by N/A N/A and N/A N/A among others.

Question 5

Did an insider recently sell SLXN stock?

Accepted Answer

Company executives, directors, and other insiders own 8.28% percent of Silexion Therapeutics Ltd.'s stock. Within the last six months, there have been 1 transaction(s) in which SLXN insiders have sold stock, totaling 22.82K shares. Insiders that have sold shares include SHIRVAN MITCHELL.

Question 6

Which insider recently purchased SLXN stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Silexion Therapeutics Ltd. insiders have bought stock, totalling 0 shares

Question 7

How much of SLXN does insiders own?

Accepted Answer

Around 27.89K Silexion Therapeutics Ltd. shares are held by insiders, which represents about 8.28% of SLXN stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

SLXN CSO and CDO, Shirvan Mitchell holds the largest portfolio of the company's shares. SLXN shares owned by Shirvan total nearly 27.89 thousand.

Question 9

Which institution holds the most shares in SLXN?

Accepted Answer

CITADEL ADVISORS LLC is the largest institutional owner in SLXN which holds 20.93 thousand shares worth $26.79K or 0.65% of the total SLXN shares outstanding followed by TWO SIGMA SECURITIES, LLC with ownership of 11.66 thousand shares representing 0.36% of the SLXN ownership. MONTAG A & ASSOCIATES INC is the third largest stakeholder with 3 thousand shares or 0.09% of the ownership worth more than $3.84K.

Question 10

Is Silexion Therapeutics Ltd. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SLXN is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on SLXN's shares?

Accepted Answer

Number of SLXN shares short is 263.18K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding SLXN shares are there?

Accepted Answer

As of today, 8.69M shares of SLXN are outstanding.

Question 13

Is there many float in SLXN stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SLXN has 996.28K shares in float.

Question 14

SLXN short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SLXN is 0.4.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	CITADEL ADVISORS LLC	0.65%	20.93K	26.79K	8.72K	+71.45%
Mar 31, 2026	TWO SIGMA SECURITIES, LLC	0.36%	11.66K	14.92K	11.66K	+100.00%
Mar 31, 2026	MONTAG A & ASSOCIATES INC	0.09%	3K	3.84K	0	0
Mar 31, 2026	UBS GROUP AG	0.02%	517	662	-1.17K	-69.43%
Mar 31, 2026	PFLUG KOORY, LLC	0.01%	333	426	0	0
Mar 31, 2026	JONES FINANCIAL COMPANIES LLLP	0%	26	32	0	0
Mar 31, 2026	SBI SECURITIES CO., LTD.	0%	20	26	-1.04K	-98.11%

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	CITADEL ADVISORS LLC	0.65%	20.93K	26.79K	8.72K	+71.45%
Mar 31, 2026	TWO SIGMA SECURITIES, LLC	0.36%	11.66K	14.92K	11.66K	+100.00%
Mar 31, 2026	MONTAG A & ASSOCIATES INC	0.09%	3K	3.84K	0	0
Mar 31, 2026	UBS GROUP AG	0.02%	517	662	-1.17K	-69.43%
Mar 31, 2026	PFLUG KOORY, LLC	0.01%	333	426	0	0
Mar 31, 2026	JONES FINANCIAL COMPANIES LLLP	0%	26	32	0	0
Mar 31, 2026	SBI SECURITIES CO., LTD.	0%	20	26	-1.04K	-98.11%

SLXN Stock Ownership Breakdown

Silexion Therapeutics

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions